Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Q: What does CUSIP 05337M104 represent in this 13F holders report?

CUSIP 05337M104 is the security identifier for AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in Q1 2019?

39 institutional investors reported AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share for Q1 2019. Use the holders table for investor-level position and value details.

CUSIP: 05337M104

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Shares outstanding: 98,762,388
Total 13F shares: 19,605,364
Share change: -187,834
Total reported value: $28,234,677
Price per share: $1.44
Number of holders: 39
Value change: -$885,274
Number of buys: 9
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019
Previous quarter: Q4 2018

Recent filing periods for CUSIP 05337M104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BRANDES INVESTMENT PARTNERS, LP	13F	Company	7.2%	7,119,054	$18,367,000	—	31 Dec 2018	13F
Broadfin Capital, LLC	13F	Company	3.1%	3,102,673	$8,005,000	—	31 Dec 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.8%	2,722,241	$7,023,000	—	31 Dec 2018	13F
BROWN CAPITAL MANAGEMENT LLC	13F	Company	1.1%	1,095,877	$2,827,000	—	31 Dec 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.1%	1,080,877	$2,790,000	—	31 Dec 2018	13F
Tekla Capital Management LLC	13F	Company	0.82%	814,588	$2,102,000	—	31 Dec 2018	13F
MORGAN STANLEY	13F	Company	0.73%	722,019	$1,863,000	—	31 Dec 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.63%	621,500	$1,603,000	—	31 Dec 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.51%	503,800	$1,300,000	—	31 Dec 2018	13F
JW Asset Management, LLC	13F	Company	0.45%	444,439	$1,147,000	—	31 Dec 2018	13F
Fosun International Ltd	13F	Company	0.34%	337,043	$826,000	—	31 Dec 2018	13F
Janney Montgomery Scott LLC	13F	Company	0.14%	141,856	$366,000	—	31 Dec 2018	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.1%	98,000	$253,000	—	31 Dec 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	96,885	$250,000	—	31 Dec 2018	13F
STATE STREET CORP	13F	Company	0.09%	89,192	$230,000	—	31 Dec 2018	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	84,500	$218,000	—	31 Dec 2018	13F
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS	13F	Company	0.08%	77,918	$201,000	—	31 Dec 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	73,121	$189,000	—	31 Dec 2018	13F
S.c.a. Candriam	13F	Individual	0.06%	62,000	$160,000	—	31 Dec 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.06%	59,146	$153,000	—	31 Dec 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.05%	45,844	$118,000	—	31 Dec 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	36,999	$95,000	—	31 Dec 2018	13F
EATON VANCE MANAGEMENT	13F	Company	0.04%	34,700	$90,000	—	31 Dec 2018	13F
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV	13F	Company	0.03%	34,250	$88,000	—	31 Dec 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	33,382	$86,000	—	31 Dec 2018	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.03%	28,941	$74,773	—	31 Dec 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	23,905	$61,000	—	31 Dec 2018	13F
State of Tennessee, Department of Treasury	13F	Company	0.02%	23,291	$60,000	—	31 Dec 2018	13F
Paloma Partners Management Co	13F	Company	0.02%	22,970	$59,000	—	31 Dec 2018	13F
Lombard Odier SCmA Compagnie	13F	Individual	0.02%	19,000	$49,000	—	31 Dec 2018	13F
NORTHERN TRUST CORP	13F	Company	0.02%	17,184	$44,000	—	31 Dec 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	16,000	$41,000	—	31 Dec 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	15,555	$40,000	—	31 Dec 2018	13F
State of New Jersey Common Pension Fund D	13F	Company	0.01%	14,016	$36,000	—	31 Dec 2018	13F
HRT FINANCIAL LP	13F	Company	0.01%	13,174	$33,000	—	31 Dec 2018	13F
US BANCORP \DE\	13F	Company	0.01%	12,500	$32,000	—	31 Dec 2018	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	0.01%	10,637	$27,000	—	31 Dec 2018	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	10,349	$27,000	—	31 Dec 2018	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0.01%	10,000	$26,000	—	31 Dec 2018	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	0.01%	5,300	$14,000	—	31 Dec 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	4,819	$12,000	—	31 Dec 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	4,700	$12,000	—	31 Dec 2018	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	3,981	$10,000	—	31 Dec 2018	13F
CITIGROUP INC	13F	Company	0%	3,438	$9,000	—	31 Dec 2018	13F
UBS Group AG	13F	Company	0%	3,179	$8,000	—	31 Dec 2018	13F
TrinityBridge Ltd	13F	Company	0%	162	$7,000	—	31 Dec 2018	13F
Claro Advisors Inc.	13F	Company	0%	1,000	$4,000	—	31 Dec 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,001	$3,000	—	31 Dec 2018	13F
IFP Advisors, Inc	13F	Company	0%	1,000	$2,000	—	31 Dec 2018	13F
BALDWIN WEALTH PARTNERS LLC/MA	13F	Company	0%	800	$2,000	—	31 Dec 2018	13F

Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q1 2019

As of 31 Mar 2019, Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,605,364 shares. The largest 10 holders included BRANDES INVESTMENT PARTNERS, LP, Broadfin Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BROWN CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, Tekla Capital Management LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and AMERIPRISE FINANCIAL INC. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders

Q1 2019 holders

Holder diff

-10

Investor	Q4 2018 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q4 2018 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.